KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Twist Bioscience (TWST) Other Gross PP&E Adjustments (2018 - 2026)

Twist Bioscience has reported Other Gross PP&E Adjustments over the past 9 years, most recently at $146.5 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 12.18% to $146.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $146.5 million through Mar 2026, up 12.18% year-over-year, with the annual reading at $134.5 million for FY2025, 26.99% up from the prior year.
  • Other Gross PP&E Adjustments was $146.5 million for Q1 2026 at Twist Bioscience, up from $133.0 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $146.5 million in Q1 2026 and troughed at -$84.4 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $115.7 million (2024), against an average of $95.0 million.
  • The largest YoY upside for Other Gross PP&E Adjustments was 640.46% in 2022 against a maximum downside of 172.21% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $106.8 million in 2022, then rose by 7.45% to $114.7 million in 2023, then rose by 9.45% to $125.6 million in 2024, then grew by 5.92% to $133.0 million in 2025, then increased by 10.12% to $146.5 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Other Gross PP&E Adjustments are $146.5 million (Q1 2026), $133.0 million (Q4 2025), and $134.5 million (Q3 2025).